4:58 PM
 | 
May 18, 2010
 |  BC Extra  |  Company News

Icahn ups Genzyme stake

In an SEC filing, Icahn Capital LP disclosed that it held 10.5 million shares of Genzyme Corp. (NASDAQ:GENZ) as of March 31, up from 4.8 million shares...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >